Report Detail

Other Global Nucleic-Acid Based Gene Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3771915
  • |
  • 23 September, 2019
  • |
  • Global
  • |
  • 123 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Nucleic acid-based molecules are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.

Scope of the Report:
The global Nucleic-Acid Based Gene Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nucleic-Acid Based Gene Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Nucleic-Acid Based Gene Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nucleic-Acid Based Gene Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Wave Life Sciences
Phylogica
Benitec Biopharma
Celsion
Copernicus Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
DNA
RNA

Market Segment by Applications, can be divided into
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Hospitals and Diagnostic Centers
Others


Table of Contents

    1 Nucleic-Acid Based Gene Therapeutics Market Overview

    • 1.1 Product Overview and Scope of Nucleic-Acid Based Gene Therapeutics
    • 1.2 Classification of Nucleic-Acid Based Gene Therapeutics by Types
      • 1.2.1 Global Nucleic-Acid Based Gene Therapeutics Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Types in 2018
      • 1.2.3 DNA
      • 1.2.4 RNA
    • 1.3 Global Nucleic-Acid Based Gene Therapeutics Market by Application
      • 1.3.1 Global Nucleic-Acid Based Gene Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Academic and Government Research Institutes
      • 1.3.3 Pharmaceutical and Biotechnology Companies
      • 1.3.4 Contract Research Organizations
      • 1.3.5 Hospitals and Diagnostic Centers
      • 1.3.6 Others
    • 1.4 Global Nucleic-Acid Based Gene Therapeutics Market by Regions
      • 1.4.1 Global Nucleic-Acid Based Gene Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Nucleic-Acid Based Gene Therapeutics (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Wave Life Sciences
      • 2.1.1 Business Overview
      • 2.1.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Phylogica
      • 2.2.1 Business Overview
      • 2.2.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Phylogica Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Benitec Biopharma
      • 2.3.1 Business Overview
      • 2.3.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Celsion
      • 2.4.1 Business Overview
      • 2.4.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Celsion Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Copernicus Therapeutics
      • 2.5.1 Business Overview
      • 2.5.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Nucleic-Acid Based Gene Therapeutics Market Competition, by Players

    • 3.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Nucleic-Acid Based Gene Therapeutics Players Market Share
      • 3.2.2 Top 10 Nucleic-Acid Based Gene Therapeutics Players Market Share
    • 3.3 Market Competition Trend

    4 Global Nucleic-Acid Based Gene Therapeutics Market Size by Regions

    • 4.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Market Share by Regions
    • 4.2 North America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.5 South America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)

    5 North America Nucleic-Acid Based Gene Therapeutics Revenue by Countries

    • 5.1 North America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
    • 5.2 USA Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)

    6 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Countries

    • 6.1 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
    • 6.2 Germany Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.3 UK Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.4 France Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Countries

    • 7.1 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
    • 7.2 China Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.5 India Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)

    8 South America Nucleic-Acid Based Gene Therapeutics Revenue by Countries

    • 8.1 South America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
    • 8.2 Brazil Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Nucleic-Acid Based Gene Therapeutics by Countries

    • 9.1 Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)

    10 Global Nucleic-Acid Based Gene Therapeutics Market Segment by Type

    • 10.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Nucleic-Acid Based Gene Therapeutics Market Forecast by Type (2019-2024)
    • 10.3 DNA Revenue Growth Rate (2014-2024)
    • 10.4 RNA Revenue Growth Rate (2014-2024)

    11 Global Nucleic-Acid Based Gene Therapeutics Market Segment by Application

    • 11.1 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Application (2014-2019)
    • 11.2 Nucleic-Acid Based Gene Therapeutics Market Forecast by Application (2019-2024)
    • 11.3 Academic and Government Research Institutes Revenue Growth (2014-2019)
    • 11.4 Pharmaceutical and Biotechnology Companies Revenue Growth (2014-2019)
    • 11.5 Contract Research Organizations Revenue Growth (2014-2019)
    • 11.6 Hospitals and Diagnostic Centers Revenue Growth (2014-2019)
    • 11.7 Others Revenue Growth (2014-2019)

    12 Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast (2019-2024)

    • 12.1 Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast (2019-2024)
    • 12.2 Global Nucleic-Acid Based Gene Therapeutics Market Forecast by Regions (2019-2024)
    • 12.3 North America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
    • 12.4 Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
    • 12.6 South America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Nucleic-Acid Based Gene Therapeutics. Industry analysis & Market Report on Nucleic-Acid Based Gene Therapeutics is a syndicated market report, published as Global Nucleic-Acid Based Gene Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Nucleic-Acid Based Gene Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,690.04
      4,035.06
      5,380.08
      3,208.56
      4,812.84
      6,417.12
      531,604.80
      797,407.20
      1,063,209.60
      292,702.80
      439,054.20
      585,405.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report